Gut check: semaglutide study probes hidden bacteria link
NCT ID NCT07323134
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This study looks at how the weight-loss drug semaglutide changes the gut bacteria in 40 adults with obesity. Participants will take semaglutide for 12 weeks, and researchers will analyze their stool samples to see how the bacteria in their intestines shift. The goal is to better understand how semaglutide works, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.